BOOT vs. CORT

In the year-to-date period, BOOT achieves a 92.78% return, which is significantly higher than CORT's 56.71% return. Over the past 10 years, BOOT has underperformed CORT with an annualized return of 23.23%, while CORT has yielded a comparatively higher 32.64% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Boot Barn Holdings, Inc. (BOOT) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BOOT Sharpe Ratio is 2.01, which is higher than the CORT Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of BOOT and CORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BOOT nor CORT has paid dividends to shareholders.

The maximum BOOT drawdown since its inception was -83.73%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for BOOT and CORT. For additional features, visit the drawdowns tool.

Boot Barn Holdings, Inc. (BOOT) has a higher volatility of 12.90% compared to Corcept Therapeutics Incorporated (CORT) at 11.44%. This indicates that BOOT's price experiences larger fluctuations and is considered to be riskier than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Boot Barn Holdings, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.